Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Adagio Medical Holdings Inc (ADGM)

Adagio Medical Holdings Inc (ADGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Adagio Medical Holdings Inc 26051 MERIT CIRCLE SUITE 102 LAGUNA HILLS CA 92653 USA

www.adagiomedical.com Employees: 71 P: 949-348-1188

Sector:

Medical

INDUSTRY GROUPING:

Medical Instruments

Description:

Adagio Medical is a developmental stage medical device company which focuses on developing cryoablation technologies which create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter and ventricular tachycardia. Adagio Medical, formerly known as ARYA Sciences Acquisition Corp IV, is based in LAGUNA HILLS, Calif.

Key Statistics

Overview:

Market Capitalization, $K 20,333
Enterprise Value, $K 15,823
Shares Outstanding, K 21,180
Float, K 20,079
% Float 94.80%
Short Interest, K 74
Short Float 0.35%
Days to Cover 1.33
Short Volume Ratio 0.05
% of Insider Shareholders 5.20%
% of Institutional Shareholders 48.08%

Financials:

Annual Sales, $ 600 K
Annual Net Income, $ -75,040 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,120 K
EBIT, $ -65,930 K
EBITDA, $ -34,210 K

Growth:

1-Year Return -5.76%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.66 on 11/12/25
Next Earnings Date 03/11/26 [--]
Earnings Per Share ttm -1.52
EPS Growth vs. Prev Qtr -88.57%
EPS Growth vs. Prev Year -39.54%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ADGM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -791.00%
Return-on-Assets % -199.58%
Profit Margin % -12,506.67%
Debt/Equity -16.18
Price/Sales 43.26
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.09
Interest Coverage -24.70
60-Month Beta 0.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar